PON1 and neoplasm: The decrease in PON1 activity was found in the blood serum of patients with genital tract neoplasms, including endometrial cancer [131], with colorectal [132] and bladder [133] cancers, while the lower PON1 concentration was observed in patients with tumor recurrence compared with patients without relapse [134].